Trident Mediquip Profile
Key Indicators
- Authorised Capital ₹ 8.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 7.78 Cr
as on 23-10-2024
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 15.56 Cr
as on 23-10-2024
- Satisfied Charges ₹ 8.88 Cr
as on 23-10-2024
- Revenue -9.13%
(FY 2023)
- Profit -88.89%
(FY 2023)
- Ebitda -129.96%
(FY 2023)
- Net Worth 0.39%
(FY 2023)
- Total Assets 25.61%
(FY 2023)
About Trident Mediquip
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 7.78 Cr.
The company currently has active open charges totaling ₹15.56 Cr. The company has closed loans amounting to ₹8.88 Cr, as per Ministry of Corporate Affairs (MCA) records.
Hardik Desai, Chetan Jariwala, Nachiket Amin, and Two other members serve as directors at the Company.
- CIN/LLPIN
U33309GJ2019PLC110421
- Company No.
110421
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
19 Oct 2019
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Trident Mediquip?
Board Members(5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Hardik Desai | Director | 01-Oct-2020 | Current |
Chetan Jariwala | Director | 19-Oct-2019 | Current |
Nachiket Amin | Director | 19-Oct-2019 | Current |
Amit Halvawala | Director | 19-Oct-2019 | Current |
Vishal Halvawala | Director | 01-Oct-2020 | Current |
Financial Performance of Trident Mediquip.
Trident Mediquip Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.13% decrease. The company also saw a substantial fall in profitability, with a 88.89% decrease in profit. The company's net worth moved up by a moderate rise of 0.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Trident Mediquip?
In 2023, Trident Mediquip had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Shree Santram Silk Mills LlpActive 7 years 10 days
Hardik Desai and Chetan Jariwala are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 30 Jan 2024 | ₹9.90 Cr | Open |
Standard Chartered Bank Creation Date: 27 Apr 2023 | ₹2.00 Cr | Open |
Sidbi Creation Date: 18 Feb 2021 | ₹3.66 Cr | Open |
How Many Employees Work at Trident Mediquip?
Trident Mediquip has a workforce of 138 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trident Mediquip, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trident Mediquip's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.